Davis Polk advised the joint book-running managers in connection with a $69 million SEC-registered common stock offering by Corvus Pharmaceuticals, Inc. Credit Suisse, Jefferies, Guggenheim Securities…
Corvus Pharmaceuticals, Inc. $69 Million Common Stock Offering
